Is the combination of resmetirom and semaglutide useful for the treatment of metabolic dysfunction‐associated steatohepatitis?

Diabetes Obesity and Metabolism 2026

View at publisher
Authors: Stergios A. Polyzos, Jannis Kountouras, Leonidas H. Duntas, Giovanni Targher
DOI: 10.1111/dom.70507
Cited by: 4
References: 20

Abstract

The authors have no conflicts of interest to declare. The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1111/dom.70507. Data sharing is not applicable to this article, as no datasets were generated or analysed during the preparation of this Commentary.

Fields of Study & Subjects

Liver Disease Diagnosis and Treatment Liver Diseases and Immunity Diabetes Treatment and Management

Publication details

Journal / source
Diabetes Obesity and Metabolism
Publisher
Wiley
Volume
28
Issue
4
Pages
2507–2510
Publication date
20 January 2026
Language
EN